• Notice of Annual General Meeting in Vivesto AB

    April 8, 2025

    Read more

  • Report from Annual General Meeting in Vivesto AB

    May 8, 2025

    Read more

  • Annual report 2024

    April 8, 2025
    (Only distributed in Swedish)

    Read the report

  • First patient dosed in Vivesto’s Paccal Vet dose-finding study in cats

    August 14, 2025

    Read more

Vivesto licenses Apealea to China’s Zhida Pharmaceutical

March 18, 2025

Read more

CEO corner

Learn more (in Swedish)

Press releases

All press releases

Interim Report Q2 2025 (in Swedish)

Vivesto published its Q2 report for 2025 on August 12, 2025, at 08.00 am CEST.

Calendar

All events

The Share

Follow the share
Visit our Investor section

Annual Report 2024

Read the report